Reuters

Private Equity Steps up for Baxter Biopharma

A private equity consortium of Warburg Pincus and Advent International is said to be in advanced talks to acquire medical device maker Baxter International’s biopharma solutions business. The deal could be worth $4 billion or more, news agencies and the newspaper Wall Street Journal reported.

Reuters Talc Report Stuns J&J and the Markets

Fires Strike Two Texas Refineries

Air Products and Evonik Close to Performance Materials Deal?

AstraZeneca Shareholders Target CEO Pay

Sanofi Gives Back Insulin Drug to MannKind

Will Consolidation Force Bayer’s Hand?

DuPont May Sell its Own Agricultural Business

Dow’s Mooted Ag Sale Sparks Speculation

Japan Agrees Projects Worth $26 Billion in Central Asia

Lanxess CEO Says China Concerns Overblown

Fire at Hexion in Texas Put Out

Lanxess Talking to Ineos About Rubber

China’s Sinopec to Buy Stake in Russia’s Sibur

Syngenta Plans Share Buyback and Seed Divestment

Canada’s Potash Poised to Grab Germany’s K+S

Teva and Mylan Slug it out Over Takeover Bid

BASF Said Eyeing Syngenta as Monsanto Tightens Screws

Monsanto Seen Working on a New Bid for Syngenta

Clariant Sees Shareholders as Bulwark Against Takeovers

Mylan Said to Prepare Poison Pill Potion Against Teva

SABIC in Shale Gas Deal With Unnamed US Supplier

Residues of Glyphosate Found in Food and Body Fluids

Baumann Says He’ll Fight to Keep Bayer Independent

Syngenta Said to Mull Countersuits in Corn Seed Dispute

Chemical Plant Blast Near Barcelona Injures Thre

Shell Building $11 Billion Petchems Complex in Iraq

Pfizer to Pay $400 million to Avert Class Action Trial

Fired Sanofi CEO to Receive $4.4 Million Severance Pay

GSK Chief Sees More Unit IPOs as Options

Saudi Aramco May Halt Ras Tanura Clean Fuels Project

EU Leaders Beat the Drum Harder for TTIP

Feud Arises Over Planned Sale of Sika to Saint-Gobain

Merck & Co Still Plans to buy Cubist, Despite Patent Setback

Eni to Pull out of Polish Shale Gas exploration?